Your browser doesn't support javascript.
loading
Gender medicine and oncology: report and consensus of an ESMO workshop.
Wagner, A D; Oertelt-Prigione, S; Adjei, A; Buclin, T; Cristina, V; Csajka, C; Coukos, G; Dafni, U; Dotto, G-P; Ducreux, M; Fellay, J; Haanen, J; Hocquelet, A; Klinge, I; Lemmens, V; Letsch, A; Mauer, M; Moehler, M; Peters, S; Özdemir, B C.
Afiliación
  • Wagner AD; Department of Oncology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland. Electronic address: Dorothea.wagner@chuv.ch.
  • Oertelt-Prigione S; Department of Primary and Community Care, Radboud Institute of Health Sciences (RIHS), Radboud University Medical Center, Nijmegen, The Netherlands.
  • Adjei A; Department of Oncology, Mayo Clinic, Rochester, USA.
  • Buclin T; Service of Clinical Pharmacology, Lausanne University, Lausanne.
  • Cristina V; Department of Oncology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Csajka C; Service of Clinical Pharmacology, Lausanne University, Lausanne; Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, University of Lausanne, Lausanne.
  • Coukos G; Department of Oncology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland; Ludwig Lausanne Branch and Swiss Cancer Center, Lausanne, Switzerland.
  • Dafni U; Department of Oncology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland; National and Kapodistrian University of Athens, Athens, Greece.
  • Dotto GP; Department of Biochemistry, Lausanne University, Lausanne, Switzerland; Massachusetts General Hospital, Boston, USA; International Cancer Prevention Institute, Epalinges, Switzerland.
  • Ducreux M; Gastrointestinal Cancer Unit, Gustave Roussy, Paris Saclay University, Villejuif, France.
  • Fellay J; Precision Medicine Unit, Lausanne University Hospital and University of Lausanne, Lausanne; EPFL School of Life Sciences, Lausanne, Switzerland.
  • Haanen J; Division of Medical Oncology and Immunology, Department of Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Hocquelet A; Department of Radiodiagnostic and Interventional Radiology, Lausanne University Hospital, Lausanne, Switzerland.
  • Klinge I; Dutch Society for Gender and Health.
  • Lemmens V; Department of Research and Development, Comprehensive Cancer Organisation the Netherlands, Utrecht; Department of Public Health, Erasmus Medical Centre University, Rotterdam, The Netherlands.
  • Letsch A; Department of Hematology and Oncology, Charity CBF, Berlin; Charity Comprehensive Cancer Center CCCC, Berlin; Palliative Care Unit, Campus Benjamin Franklin, Berlin, Germany.
  • Mauer M; EORTC, Brussels, Belgium.
  • Moehler M; Department of Internal Medicine 1/Gastrointestinal Oncology, Johannes-Gutenberg-University Clinic, Mainz, Germany.
  • Peters S; Department of Oncology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Özdemir BC; Department of Oncology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland; International Cancer Prevention Institute, Epalinges, Switzerland.
Ann Oncol ; 30(12): 1914-1924, 2019 12 01.
Article en En | MEDLINE | ID: mdl-31613312

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Caracteres Sexuales / Oncología Médica / Neoplasias Tipo de estudio: Prognostic_studies Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Caracteres Sexuales / Oncología Médica / Neoplasias Tipo de estudio: Prognostic_studies Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article